<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sacre S</submitter><funding>Medical Research Council</funding><pagination>1167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6542943</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10</volume><pubmed_abstract>Antidepressants are increasingly recognized to have anti-inflammatory properties in addition to their ability to treat major depressive disorders. To explore if engagement of 5-hydroxytryptamine (5-HT) receptors was required for the anti-inflammatory effect of the tetracyclic antidepressant mianserin, a series of structural derivatives were generated with the aim of reducing 5-HT receptor binding. Primary human peripheral blood mononuclear cells were used to screen for anti-inflammatory activity. The lead compound demonstrated a significant loss in 5-HT receptor binding, as assessed by non-selective 5-HT binding of radiolabelled serotonin in rat cerebral cortex. However, it retained the ability to inhibit endosomal toll-like receptor 8 signaling in primary human macrophages and spontaneous</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Structural Modification of the Antidepressant Mianserin Suggests That Its Anti-inflammatory Activity May Be Independent of 5-Hydroxytryptamine Receptors.</pubmed_title><pmcid>PMC6542943</pmcid><funding_grant_id>G1001715</funding_grant_id><pubmed_authors>Jaxa-Chamiec A</pubmed_authors><pubmed_authors>Sacre S</pubmed_authors><pubmed_authors>Tralau-Stewart C</pubmed_authors><pubmed_authors>Chamberlain G</pubmed_authors><pubmed_authors>Low CMR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural Modification of the Antidepressant Mianserin Suggests That Its Anti-inflammatory Activity May Be Independent of 5-Hydroxytryptamine Receptors.</name><description>Antidepressants are increasingly recognized to have anti-inflammatory properties in addition to their ability to treat major depressive disorders. To explore if engagement of 5-hydroxytryptamine (5-HT) receptors was required for the anti-inflammatory effect of the tetracyclic antidepressant mianserin, a series of structural derivatives were generated with the aim of reducing 5-HT receptor binding. Primary human peripheral blood mononuclear cells were used to screen for anti-inflammatory activity. The lead compound demonstrated a significant loss in 5-HT receptor binding, as assessed by non-selective 5-HT binding of radiolabelled serotonin in rat cerebral cortex. However, it retained the ability to inhibit endosomal toll-like receptor 8 signaling in primary human macrophages and spontaneous</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-18T20:39:33.489Z</modification><creation>2019-07-24T07:07:16Z</creation></dates><accession>S-EPMC6542943</accession><cross_references><pubmed>31244825</pubmed><doi>10.3389/fimmu.2019.01167</doi></cross_references></HashMap>